Effect of bempedoic acid plus ezetimibe fixed-dose combination vs ezetimibe or placebo on low-density lipoprotein cholesterol in patients with type 2 diabetes and hypercholesterolemia not treated with statins

• Asıl Yazarlar: Harold E. Bays (Yazar), Seth J. Baum (Yazar), Eliot A. Brinton (Yazar), Jorge Plutzky (Yazar), Jeffrey C. Hanselman (Yazar), Rujun Teng (Yazar), Christie M. Ballantyne (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2021-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Objective: Statins are sometimes associated with worsened glycemic control. Patients with type 2 diabetes mellitus (T2DM) may require non-statin therapies to achieve low-density lipoprotein cholesterol (LDL-C) lowering goals. This study evaluated the efficacy and safety of bempedoic acid 180 mg plus...